{"schema_version":"1","generated_at":"2026-10-30T21:46:13.088Z","data_as_of":"2026-10-28","url":"https://www.findmykol.com/kol/bassem-chehab","json_url":"https://www.findmykol.com/kol/bassem-chehab/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"bassem-chehab","name":"Bassem Chehab","credential":"MD","title":"Medical director, Heart Valve Clinic and Structural Heart program, Ascension Via Christi St. Francis","specialty":"Cardiovascular Disease","specialty_raw":"Cardiovascular Disease","therapeutic_area":"Cardiology","therapeutic_areas":["Cardiology"],"institution":"Ascension Via Christi Cardiology","institution_url":"https://www.findmykol.com/institution/ascension-via-christi-cardiology","city":"Wichita","state":"KS","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1710006820","orcid":"0000-0003-1267-4726","openalex":"A5084120719"},"summary":"Bassem Chehab is Medical director, Heart Valve Clinic and Structural Heart program, Ascension Via Christi St. Francis at Ascension Via Christi Cardiology. OpenAlex indexes 90 publications with 1,381 citations (h-index 20); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.","overview":{"text":"Bassem Chehab, M.D., is Medical director, Heart Valve Clinic and Structural Heart program, Ascension Via Christi St. Francis at Ascension Via Christi Cardiology. The public record shows 90 publications with 1,381 citations (h-index 20), centered on Coronary Interventions and Diagnostics, Cardiac Valve Diseases and Treatments, Antiplatelet Therapy and Cardiovascular Diseases. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 32 companies.","bullets":["Top research focus: Coronary Interventions and Diagnostics","9 registered trials on ClinicalTrials.gov","Open Payments reporting from 32 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Coronary Artery Disease / ACS","therapeutic_area":"Cardiology","trials":3,"topics":1,"strength":10},{"label":"Constriction, Pathologic","therapeutic_area":"Epidemiology","trials":3,"topics":0,"strength":9},{"label":"Aortic Valve Stenosis","therapeutic_area":"Cardiology","trials":2,"topics":0,"strength":6},{"label":"Heart Valve Diseases","therapeutic_area":"Cardiology","trials":2,"topics":0,"strength":6},{"label":"Aortic Valve Disease","therapeutic_area":"Cardiology","trials":2,"topics":0,"strength":6},{"label":"Coronary Artery Disease","therapeutic_area":"Cardiology","trials":2,"topics":0,"strength":6},{"label":"Myocardial Infarction","therapeutic_area":"Cardiology","trials":2,"topics":0,"strength":6},{"label":"Infarction","therapeutic_area":"Cardiology","trials":2,"topics":0,"strength":6},{"label":"Tricuspid Valve Insufficiency","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Hypertension","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Cardiovascular Diseases","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Vascular Diseases","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"ST Elevation Myocardial Infarction","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Mitral Valve Insufficiency","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Mitral Valve Stenosis","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3}],"research_topics":["Coronary Interventions and Diagnostics","Cardiac Valve Diseases and Treatments","Antiplatelet Therapy and Cardiovascular Diseases","Aortic Disease and Treatment Approaches","Acute Myocardial Infarction Research"],"drugs_studied":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"Eliquis","generic":"Apixaban","trials":0,"payments":1,"publications":0,"mentions":1},{"name":"Nirmatrelvir","trials":0,"payments":1,"publications":0,"mentions":1},{"name":"Wegovy","generic":"Semaglutide","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":30,"shown":3,"withheld":27,"rows":[{"name":"ReCor Medical, Inc.","trials":1,"payments":6,"mentions":7},{"name":"Abbott Laboratories","trials":0,"payments":348,"mentions":348},{"name":"Edwards Lifesciences Corporation","trials":0,"payments":200,"mentions":200}]}},"scholarship":{"works_count":90,"cited_by_count":1381,"h_index":20,"i10_index":25,"pubmed_count":5,"latest_activity_year":2025,"source":"works"},"trials":{"count":9,"shown":3,"withheld":6,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07069673","title":"Abbott Cephea Mitral Valve Disease Registry","status":"RECRUITING","role":"Investigator","sponsor":"Abbott Medical Devices","source_url":"https://clinicaltrials.gov/study/NCT07069673","trial_url":"https://www.findmykol.com/trial/NCT07069673"},{"nct":"NCT06777368","title":"REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE","status":"RECRUITING","role":"Investigator","sponsor":"Medtronic Cardiovascular","source_url":"https://clinicaltrials.gov/study/NCT06777368","trial_url":"https://www.findmykol.com/trial/NCT06777368"},{"nct":"NCT06535854","title":"Prevail Global Study","phase":"NA","status":"RECRUITING","role":"Investigator","sponsor":"Medtronic Vascular","source_url":"https://clinicaltrials.gov/study/NCT06535854","trial_url":"https://www.findmykol.com/trial/NCT06535854"}],"source":"trials"},"payments":{"company_count":32,"program_years":{"first":2021,"last":2025},"rows_total":62,"shown":3,"withheld":59,"rows":[{"payer":"Abbott Laboratories","program_year":2025,"amount_usd":45988.87,"payment_count":55,"source_url":"https://openpaymentsdata.cms.gov/search?query=1710006820"},{"payer":"Edwards Lifesciences Corporation","program_year":2025,"amount_usd":18251.21,"payment_count":28,"source_url":"https://openpaymentsdata.cms.gov/search?query=1710006820"},{"payer":"ABIOMED","program_year":2025,"amount_usd":8527.81,"payment_count":13,"source_url":"https://openpaymentsdata.cms.gov/search?query=1710006820"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1710006820","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Cardiovascular","share_pct":78.1,"classes_total":19,"classes":[{"class":"Beta blocker","setting":"prescribed","share_pct":18.2,"drugs":[{"name":"Metoprolol Tartrate","share_pct":53.6},{"name":"Carvedilol","share_pct":24.3},{"name":"Metoprolol Succinate","share_pct":19.5},{"name":"Sotalol","share_pct":1.7},{"name":"Atenolol","share_pct":0.9}],"max_beneficiaries":null},{"class":"Loop diuretic","setting":"prescribed","share_pct":13.3,"drugs":[{"name":"Furosemide","share_pct":78.3},{"name":"Bumetanide","share_pct":20.4},{"name":"Torsemide","share_pct":1.3}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":15.9,"classes_total":4,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":8.5,"drugs":[{"name":"Eliquis","share_pct":80.1},{"name":"Xarelto","share_pct":19.9}],"max_beneficiaries":127},{"class":"P2Y12 inhibitor","setting":"prescribed","share_pct":5.5,"drugs":[{"name":"Clopidogrel","share_pct":91.4},{"name":"Brilinta","share_pct":6.2},{"name":"Prasugrel Hcl","share_pct":2.4}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":5.8,"classes_total":4,"classes":[{"class":"Potassium supplement","setting":"prescribed","share_pct":3.1,"drugs":[{"name":"Potassium Chloride","share_pct":90},{"name":"Klor-Con M20","share_pct":10}],"max_beneficiaries":84},{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":2.5,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":77}]}],"care_setting":{"dominant":"mixed","data_year":2024,"office_pct":58.1,"facility_pct":41.9},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"publications":{"total":5,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR Score","year":2026,"journal":"JACC: Cardiovascular Interventions","source_url":"https://doi.org/10.1016/j.jcin.2026.04.051","status":"verified"},{"title":"Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial","year":2025,"journal":"European Heart Journal","source_url":"https://doi.org/10.1093/eurheartj/ehaf676","status":"verified"},{"title":"Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trial","year":2025,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(25)02073-2","status":"verified"},{"title":"Transcatheter Mitral Valve Replacement for Severe Mitral Annular Calcification","year":2025,"journal":"Journal of the American College of Cardiology","source_url":"https://doi.org/10.1016/j.jacc.2025.10.025","status":"verified"},{"title":"1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI","year":2025,"journal":"JACC: Cardiovascular Interventions","source_url":"https://doi.org/10.1016/j.jcin.2025.01.424","status":"verified"}],"most_cited":{"total":90,"shown":5,"withheld":85,"rows":[{"title":"Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial","year":2020,"cited_by_count":143,"type":"article","source_url":"https://doi.org/10.1016/s0140-6736(20)31358-1"},{"title":"1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study","year":2023,"cited_by_count":138,"type":"article","source_url":"https://doi.org/10.1016/j.jcin.2023.09.029"},{"title":"Contemporary Outcomes Following Transcatheter Edge-to-Edge Repair","year":2023,"cited_by_count":108,"type":"article","source_url":"https://doi.org/10.1016/j.jcin.2023.01.010"},{"title":"3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation","year":2021,"cited_by_count":106,"type":"article","source_url":"https://doi.org/10.1016/j.jcin.2021.07.016"},{"title":"Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI","year":2021,"cited_by_count":82,"type":"article","source_url":"https://doi.org/10.1016/j.jacc.2021.08.074"}]},"source":"works"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Raj Makkar","coauthored_works":20,"profile_url":"https://www.findmykol.com/kol/raj-makkar"},{"name":"Aziz R. Maksoud","coauthored_works":18},{"name":"Federico M. Asch","coauthored_works":17}],"source":"works"},"recognition":{"education":{"total":4,"shown":4,"rows":[{"value":"MD","source_url":"https://healthcare.ascension.org/find-care/provider/1710006820/bassem-chehab","status":"verified","collected_at":"2026-10-28"},{"value":"Medical education: Lebanese University Faculty of Medical Sciences","source_url":"https://healthcare.ascension.org/find-care/provider/1710006820/bassem-chehab","status":"verified","collected_at":"2026-10-28"},{"value":"Board certification: American Board of Internal Medicine, Cardiovascular Disease","source_url":"https://healthcare.ascension.org/find-care/provider/1710006820/bassem-chehab","status":"verified","collected_at":"2026-10-28"},{"value":"Board certification: American Board of Internal Medicine, Interventional Cardiology","source_url":"https://healthcare.ascension.org/find-care/provider/1710006820/bassem-chehab","status":"verified","collected_at":"2026-10-28"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Fellow, Society of Coronary Angiography Interventions (2018)","source_url":"https://www.doximity.com/pub/bassem-chehab-md","status":"provisional","collected_at":"2026-10-28"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Ascension Via Christi St. Francis (hospital affiliation)","source_url":"https://healthcare.ascension.org/find-care/provider/1710006820/bassem-chehab","status":"verified","collected_at":"2026-10-28"}]}},"similar":[{"name":"Deepak Bhatt","slug":"deepak-bhatt","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/deepak-bhatt","json_url":"https://www.findmykol.com/kol/deepak-bhatt/profile.json"},{"name":"Harlan Krumholz","slug":"harlan-krumholz","institution":"Yale School of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/harlan-krumholz","json_url":"https://www.findmykol.com/kol/harlan-krumholz/profile.json"},{"name":"Scott Solomon","slug":"scott-solomon","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/scott-solomon","json_url":"https://www.findmykol.com/kol/scott-solomon/profile.json"},{"name":"Eric Topol","slug":"eric-topol","institution":"Scripps Research Institute (Scripps Research)","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/eric-topol","json_url":"https://www.findmykol.com/kol/eric-topol/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":6,"payments":59,"publications":45,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-28"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}